The Expression and Function of Anti-apoptotic Bfl-1 in Prostate Cancer

LI Xing-lan, CHEN Xue-qin, NIE Ling, XU Miao, LI Qiu-yao, SHANG Wei-wei, CHEN Ni, HUANG Rui, ZENG Hao, ZHOU Qiao

Abstract

To determine the expression of Bcl2 related protein A1(Bfl-1) mRNA in prostate cancer cell lines and tissues, and to explore the functions of Bfl-1 in prostate adenocarcinoma. Methods RT-PCR, real-time quantitative PCR(Q-PCR)and in situ hybridization (ISH) were used to detect the expression of Bfl-1 mRNA in prostate cancer cell lines, tissues and benign prostate hyperplasia (BPH) tissue samples. The relationship between Bfl-1 expression and clinicopathological parameters was analyzed. Antisense oligonucleotides (ASONs) were used to interfere the expression of Bfl-1 and its effects on prostate cancer cells. MTT was used to detect the survival, morphologic changes of prostate cancer cells was observed by inverted microscope. Results Bfl-1 mRNA, detected by RT-PCR, Q-PCR and ISH, was overexpressed in the androgen-independent prostate cancer cell lines PC-3 and DU145, but not detectable in the androgen-dependent prostate cancer cell line LNCaP and BPH tissue samples (P<0.05). Significantly higher Bfl-1 mRNA levels were observed in higher stage and metastatic prostate cancer cases than those without metastasis or of low stage. ASONs targeting Bfl-1 significantly inhibited androgen-independent prostate cancer cell growth (P<0.05), cell was rounding off or fragmentation. Conclusion Bfl-1 is involved in maintaining the hormone-independent prostate cancer cell growth. Bfl-1 may become a new therapeutic target in advanced prostate cancer.

 

Keywords: Bfl-1, Prostate cancer,Cell growth, Antisense oligonucleotides

 

Full Text:

PDF


References


Hudson T. Denis LJ. Europa uomo: the European prostate cancer coalition. In: Schlag PM. Recent Results in Cancer Research. Vol. 175. New York: Springer.2007:267-273.

Jemal A, Siegel R, Xu J .et al. Cancer statistics, 2010. CA Cancer J Clin,2010;60(5) ;277-300.

Nelson WG, Marzo AD. Isaacs WB. Prostate cancer. N Engl J Med.2003;349(4):366-381.

Choi SS, Park IC, Yun JW. etal. A novel Bcl-2 related gene, Bfl-1. is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene,1995; 11 (9); 1693-1698. Vogler M. BCL2A1; the underdog in the Bcl2 family. Cell Death Differ,2011; 19( 1):67-74.

Choi S, Park S, Kim UJ, etal. Bfl-1, a Bcl-2-related gene, is the human homolog of the murine Al, and maps to chromosome 15q24.3. Mamm Genome. 1997;8( 10);781-782.

Lin EY, Kozak CA, Orlofsky A, et al. The Bcl-2 family member, Bcl2al, maps to mouse chromosome 9 and human chromosome 15. Mamm Genome, 1997;8(4) ;293-294.

Ко JK, Choi KH, Pan Z, et al. The tail-anchoring domain of Bfl 1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis. J Cell Sci,2007; 120( 16) ;2912-2923.

Karsan A, Yee E. Kaushansky K. et al. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human Al in cultured endothelial cells. Blood, 1996;87(8):3089-3096.

Kenny JJ, Knobloch TJ, Augustus M, etal. GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes. Oncogene, 1997;14(8);997-1001.

Hatakeyama S, Hamasaki A, Negishi I, et al. Multiple gene duplication and expression of mouse Bcl-2-related genes, Al. Int Immunol, 1998; 10(5) :631-637.

Placzek WJ, Wei J, Kitada S, et al. A survey of the anti- apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Disease,2010; 1 (5) :e40.

Wang CY, Guttridge DC, Mayo MW. et al. NF-kappaB induces expression of the Bcl-2 homologue A1/B//-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol, 1999; 19(9):5923-5929.

Shim YH, Byun EK, Lee MJ, el al. Anti-apoptotic role of В/7-1 in staurosporine-treated B-lymphoblastic cells. Int J Hematol,2000;72(4):484-490.

Cheng Q, Lee HH, Li Y, el al. Upregulation of Bcl-x and В/7-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition. Oncogene, 2000; 19 (42):4936-4940.

Brien C, Trescol BM, Bonnefoy BN. Downregulation of Bfl-1 protein expression sensitizes malignant В cells to apoptosis. Oncogene,2007;26(39);5828-5832.


Refbacks

  • There are currently no refbacks.